Aktieanalys

Speqta Q4’21 Review: Bidbrain in Focus – Strategic Revision Continues - Redeye

{newsItem.title}

Redeye Publicerad: 14 Mar 2022 09:48

Redeye retains its positive view on Speqta, currently trading below net cash. We leave our Base Case unchanged, awaiting the revised strategy and management’s capital allocation plans.

Länk till analysen i sin helhet: https://www.redeye.se/research/836126/speqta-q421-review-bidbrain-in-focus-strategic-revision-continues?utm_source=finwire&utm_medium=RSS

Nyheter om BrightBid

Läses av andra just nu

Om aktien BrightBid

Senaste nytt